MSUT2 is a determinant of susceptibility to tau neurotoxicity
about
Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).The Drosophila ortholog of the Zc3h14 RNA binding protein acts within neurons to pattern axon projection in the developing brain.Links between mRNA splicing, mRNA quality control, and intellectual disabilityAdvances with RNA interference in Alzheimer's disease research.Proteins in aggregates functionally impact multiple neurodegenerative disease models by forming proteasome-blocking complexes.Poly(A) RNA-binding proteins and polyadenosine RNA: new members and novel functions.Hook proteins: association with Alzheimer pathology and regulatory role of hook3 in amyloid beta generationRecent advances in RNA interference therapeutics for CNS diseases.The Evolutionarily-conserved Polyadenosine RNA Binding Protein, Nab2, Cooperates with Splicing Machinery to Regulate the Fate of pre-mRNA.Functional implications of glycogen synthase kinase-3-mediated tau phosphorylationUse of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases.Invited review: Prion-like transmission and spreading of tau pathology.A conserved role for the zinc finger polyadenosine RNA binding protein, ZC3H14, in control of poly(A) tail length.The Polyadenosine RNA-binding Protein, Zinc Finger Cys3His Protein 14 (ZC3H14), Regulates the Pre-mRNA Processing of a Key ATP Synthase Subunit mRNA.Potential neuroprotective strategies against tauopathy.An AMPK-dependent regulatory pathway in tau-mediated toxicity.The RNA-binding protein, ZC3H14, is required for proper poly(A) tail length control, expression of synaptic proteins, and brain function in mice.
P2860
Q30541813-0A119E2A-C295-4FFB-AAA7-8879083CC28CQ30676992-C4C40F92-BC83-4458-8A03-37771C88261AQ33364292-74CB0BCD-3CC7-4F3A-837D-AC18CA86D83FQ34330911-81D17BA1-04F6-41AB-8903-19555353ACD4Q35080559-8A1A733C-C5E7-4B3D-AC8F-E388BEAF9D9AQ35095113-25024369-4FB6-46F0-98FD-AF3EE2E3B773Q35208328-7F778C47-47D7-4AE2-9809-FACE61D89DA6Q36983193-2C9D0874-CD31-4BD6-9E06-C83496072774Q37339449-7774AC46-1791-4433-B6EF-DE422E301932Q37903257-09B69D4F-D239-40B6-990D-CDC5A8F7E69BQ38253642-829757BC-EDE5-4EFE-9E13-A9F8BE2D8593Q38268519-C03CB3B2-9255-4E0C-AE3C-ABA9BFCD4559Q38782206-9FC67A43-8235-4CB5-B85B-65AA90D127A1Q39452096-E4783E55-825C-45EE-92D6-6BDC7465A05DQ42659976-5CAF14AC-AA56-460A-89FF-82555EDEAA0CQ47132179-7928EC6C-B77C-46B3-B35B-0C9E68BDE8F7Q48217717-AFE28F33-B45A-4157-9A28-E616F7FAC2D4
P2860
MSUT2 is a determinant of susceptibility to tau neurotoxicity
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
MSUT2 is a determinant of susceptibility to tau neurotoxicity
@ast
MSUT2 is a determinant of susceptibility to tau neurotoxicity
@en
type
label
MSUT2 is a determinant of susceptibility to tau neurotoxicity
@ast
MSUT2 is a determinant of susceptibility to tau neurotoxicity
@en
prefLabel
MSUT2 is a determinant of susceptibility to tau neurotoxicity
@ast
MSUT2 is a determinant of susceptibility to tau neurotoxicity
@en
P2093
P2860
P356
P1476
MSUT2 is a determinant of susceptibility to tau neurotoxicity
@en
P2093
Brian C Kraemer
Chris R Guthrie
Lynne Greenup
P2860
P304
P356
10.1093/HMG/DDR079
P577
2011-02-25T00:00:00Z